Načítá se...
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia
OBJECTIVE: This study evaluated the efficacy and safety of flecainide in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) on top of conventional drug therapy. BACKGROUND: CPVT is an inherited arrhythmia syndrome caused by gene mutations that destabilize cardiac ryanodine re...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3495585/ https://ncbi.nlm.nih.gov/pubmed/21616285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2011.01.026 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|